Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not

Core Insights - Solventum's (SOLV) share price has moved approximately 10% since the last update, which is considered modestly disappointing given the company's progress [1] - The broader medical device sector has also experienced a slight decline during the same period [1]